Weibo Zhong

589 total citations · 1 hit paper
12 papers, 362 citations indexed

About

Weibo Zhong is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weibo Zhong has authored 12 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weibo Zhong's work include Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (5 papers). Weibo Zhong is often cited by papers focused on Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (5 papers). Weibo Zhong collaborates with scholars based in China, United States and Hong Kong. Weibo Zhong's co-authors include Jianming Lü, Chuanfan Zhong, Xiangming Mao, Kaihui Wu, Zining Long, Taowei Yang, Yufei Guo, Daojun Lv, Xumin Zhou and Shuo Wang and has published in prestigious journals such as Frontiers in Immunology, Medicine and Cell Death and Disease.

In The Last Decade

Weibo Zhong

11 papers receiving 362 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

2022 132 citations Weibo Zhong, Kaihui Wu et al. Microbiome profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weibo Zhong China	7	246	157	85	71	26	12	362
Chuanfan Zhong China	8	267 1.1×	175 1.1×	94 1.1×	69 1.0×	25 1.0×	20	381
Weidong Wu China	12	220 0.9×	153 1.0×	94 1.1×	69 1.0×	38 1.5×	46	402
Maojun Di China	6	240 1.0×	137 0.9×	52 0.6×	101 1.4×	32 1.2×	16	353
Wang Li China	11	218 0.9×	119 0.8×	60 0.7×	50 0.7×	19 0.7×	37	348
Wei Zuo China	12	198 0.8×	103 0.7×	113 1.3×	68 1.0×	25 1.0×	37	361
Xufeng Huang Hungary	12	160 0.7×	94 0.6×	71 0.8×	109 1.5×	29 1.1×	26	364
Zhanpeng Ou China	6	217 0.9×	173 1.1×	52 0.6×	90 1.3×	21 0.8×	14	348
Zefeng Xuan China	11	211 0.9×	84 0.5×	49 0.6×	67 0.9×	24 0.9×	18	296
Xiaobo Yu China	11	317 1.3×	229 1.5×	58 0.7×	97 1.4×	22 0.8×	14	472

Countries citing papers authored by Weibo Zhong

Since Specialization

Citations

This map shows the geographic impact of Weibo Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Zhong more than expected).

Fields of papers citing papers by Weibo Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Zhong. The network helps show where Weibo Zhong may publish in the future.

Co-authorship network of co-authors of Weibo Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Weibo Zhong. A scholar is included among the top collaborators of Weibo Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibo Zhong. Weibo Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Chen, Chao‐Wei, et al.. (2025). Vitexin enhances mitophagy and improves renal ischemia-reperfusion injury by regulating the p38/MAPK pathway. Renal Failure. 47(1). 2463572–2463572. 4 indexed citations

2.

Yang, Zhenyu, Jixin Li, Weibo Zhong, et al.. (2025). Causal analysis of 731 immunophenotypes and heart failure: A bidirectional Mendelian randomization study. Medicine. 104(21). e42530–e42530. 1 indexed citations

3.

Zhong, Chuanfan, Jianming Lü, Zining Long, et al.. (2024). GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer. Cell Communication and Signaling. 22(1). 600–600. 2 indexed citations

4.

Yan, Jianjun, et al.. (2024). The immune regulatory role of exosomal miRNAs and their clinical application potential in heart failure. Frontiers in Immunology. 15. 1476865–1476865. 3 indexed citations

5.

Zhong, Weibo, et al.. (2024). CITED2 Mediates Metabolic Reprogramming in Renal Tubular Epithelial Cells via the AKT Signaling Pathway to Induce Sepsis-Associated Acute Kidney Injury. Journal of Inflammation Research. Volume 17. 9485–9505.

6.

Zhong, Chuanfan, Zining Long, Taowei Yang, et al.. (2023). M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy. International Journal of Biological Sciences. 19(5). 1543–1563. 39 indexed citations

7.

Zhong, Weibo, Kaihui Wu, Zining Long, et al.. (2022). Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis. Microbiome. 10(1). 94–94. 132 indexed citations breakdown →

8.

Zhong, Weibo, et al.. (2022). Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study. Frontiers in Immunology. 13. 1014981–1014981. 15 indexed citations

9.

Zhong, Chuanfan, Kaihui Wu, Shuo Wang, et al.. (2021). Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Cell Death and Disease. 12(8). 726–726. 27 indexed citations

10.

Wang, Ke, Weibo Zhong, Zining Long, et al.. (2021). 5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer. Frontiers in Molecular Biosciences. 8. 775304–775304. 22 indexed citations

11.

Lü, Jianming, Chuanfan Zhong, Junqi Luo, et al.. (2021). HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer. Molecular Therapy — Nucleic Acids. 26. 927–944. 33 indexed citations

12.

Wang, Shuo, Wei Su, Chuanfan Zhong, et al.. (2020). An Eight-CircRNA Assessment Model for Predicting Biochemical Recurrence in Prostate Cancer. Frontiers in Cell and Developmental Biology. 8. 599494–599494. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact